5-羟基哌啶-2-羧酸
|
H586949-1g
|
≥95% |
13096-31-6 |
1g
|
¥ 1489.9
|
期货,请咨询 |
阿拉丁 |
5-羟基哌啶-2-羧酸
|
H586949-100mg
|
≥95% |
13096-31-6 |
100mg
|
¥ 389.9
|
期货,请咨询 |
阿拉丁 |
1H-吡唑并[3,4-c]吡啶-3-胺
|
H479459-250mg
|
≥97% |
76006-17-2 |
250mg
|
¥ 194.9
|
现货 |
阿拉丁 |
1H-吡唑并[3,4-c]吡啶-3-胺
|
H479459-100mg
|
≥97% |
76006-17-2 |
100mg
|
¥ 154.9
|
现货 |
阿拉丁 |
6-杂氮-2-硫脲嘧啶
|
T665252-5g
|
≥95% |
626-08-4 |
5g
|
¥ 705.9
|
期货,请咨询 |
阿拉丁 |
6-杂氮-2-硫脲嘧啶
|
T665252-25g
|
≥95% |
626-08-4 |
25g
|
¥ 2668.9
|
期货,请咨询 |
阿拉丁 |
6-杂氮-2-硫脲嘧啶
|
T665252-1g
|
≥95% |
626-08-4 |
1g
|
¥ 227.9
|
期货,请咨询 |
阿拉丁 |
Thalidomide-Propargyne-PEG2-COOH
|
T659270-5mg
|
≥99% |
2797619-65-7 |
5mg
|
¥ 1999.9
|
期货,请咨询 |
阿拉丁 |
Thalidomide-Propargyne-PEG2-COOH
|
T659270-25mg
|
≥99% |
2797619-65-7 |
25mg
|
¥ 4999.9
|
期货,请咨询 |
阿拉丁 |
Thalidomide-Propargyne-PEG2-COOH
|
T659270-10mg
|
≥99% |
2797619-65-7 |
10mg
|
¥ 2999.9
|
期货,请咨询 |
阿拉丁 |
肼 溶液
|
H432579-25g
|
35 wt. % in H2O |
302-01-2 |
25g
|
¥ 399.9
|
现货 |
阿拉丁 |
Thalidomide-Piperazine-PEG1-NH2 diTFA
|
T658765-5mg
|
≥99% |
2357111-29-4 |
5mg
|
¥ 1699.9
|
期货,请咨询 |
阿拉丁 |
Thalidomide-Piperazine-PEG1-NH2 diTFA
|
T658765-10mg
|
≥99% |
2357111-29-4 |
10mg
|
¥ 2799.9
|
期货,请咨询 |
阿拉丁 |
4-羟甲基环己酮
|
H348400-5g
|
97% |
38580-68-6 |
5g
|
¥ 719.9
|
现货 |
阿拉丁 |
4-羟甲基环己酮
|
H348400-250mg
|
97% |
38580-68-6 |
250mg
|
¥ 69.9
|
现货 |
阿拉丁 |
4-羟甲基环己酮
|
H348400-1g
|
97% |
38580-68-6 |
1g
|
¥ 179.9
|
现货 |
阿拉丁 |
4-羟甲基环己酮
|
H348400-100mg
|
97% |
38580-68-6 |
100mg
|
¥ 39.9
|
现货 |
阿拉丁 |
1H-咪唑并[4,5-b]吡嗪
|
H192472-5g
|
≥97% |
273-94-9 |
5g
|
¥ 1683.9
|
现货 |
阿拉丁 |
1H-咪唑并[4,5-b]吡嗪
|
H192472-250mg
|
≥97% |
273-94-9 |
250mg
|
¥ 290.9
|
现货 |
阿拉丁 |
1H-咪唑并[4,5-b]吡嗪
|
H192472-1g
|
≥97% |
273-94-9 |
1g
|
¥ 799.9
|
现货 |
阿拉丁 |
1H-吡咯并[3,2-c]吡啶-4-胺
|
H176909-250mg
|
≥97% |
60290-23-5 |
250mg
|
¥ 559.9
|
期货,请咨询 |
阿拉丁 |
1H-吲唑-5-基甲醇
|
H176575-5g
|
≥97% |
478828-52-3 |
5g
|
¥ 999.9
|
现货 |
阿拉丁 |
1H-吲唑-5-基甲醇
|
H176575-250mg
|
≥97% |
478828-52-3 |
250mg
|
¥ 70.9
|
现货 |
阿拉丁 |
1H-吲唑-5-基甲醇
|
H176575-100mg
|
≥97% |
478828-52-3 |
100mg
|
¥ 36.9
|
现货 |
阿拉丁 |